Carregant...
A Cost Analysis of the 1-2-3 Pap Intervention
BACKGROUND: Cervical cancer places a substantial economic burden on our healthcare system. The three-dose human papillomavirus (HPV) vaccine series is a cost-effective intervention to prevent HPV infection and resultant cervical cancer. Despite its efficacy, completion rates are low in young women a...
Guardat en:
| Publicat a: | Front Public Health Serv Syst Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4497949/ https://ncbi.nlm.nih.gov/pubmed/26167424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.13023/FPHSSR.0403.02 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|